MEK-inhibitors/arsenic trioxide combination therapy as a novel treatment option for tyrosine kinase inhibitors-resistant ph+-leukemia

Congress of the Italian Society of Experimental Hematology (16th : Napoli, Italy : October 15-17, 2020)

Haematologica . – Vol. 105 s2 (2020) . – p s68-s69

ultimo accesso 10/05/2021 https://doi.org/10.3324/haematol.2020.s2

Nr. Estr. 8632